A Review of the Use of Transcranial Magnetic Stimulation in Psychiatric Disorders

Transcranial Magnetic Stimulation (TMS) is a minimally invasive brain stimulation technique that has been approved by the US Food and Drug Administration (FDA) in 2008 for treatment resistant depression and in 2018 for treating obsessive compulsive disorder. Over the past three decades, clinicians are beginning to use it for treatment of several psychiatric conditions, with ongoing evolving research for its potential diagnostic and therapeutic indications in a wider spectrum of medical and neuropsychiatric disorders. This review will summarize some of the potential utility of TMS as a diagnostic tool and its use in non - FDA approved indication for the treatment of depression during pregnancy, depression in the geriatric population, Schizophrenia, Bipolar disorder,Anxiety disorders, Posttraumatic stress disorder, Eating disorders, Tourette’s syndrome,Attention deficit disorder, Conversion disorder, Autism spectrum disorder, Substance use and Addictive disorders,Borderline personality disorder and Mild cognitive impairment

Keywords: Transcranial magnetic stimulation, repetitive transcranial magnetic stimulation, psychiatric disorders, review, diagnosis, treatment.